Organization

AgeX Therapeutics, Inc.

About

AgeX Therapeutics is a regenerative biotechnology company addressing some of the largest unsolved problems by focusing on developing and commercializing novel therapeutics that directly target human aging. The company's revolutionary proprietary technology platform, including iTR™ (induced Tissue Regeneration) and PureStem®, has applications in a range of degenerative diseases with high unmet medical need and regenerative ability to reverse age-related changes in the human body.

Overview

Founded 2017
Type Public
Location Alameda, California, USA

Stock

AGE $0.00 0.00% $0.00

Latest News

Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday Jul 06, 2022 Benzinga Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. Rubicon Technology, Inc. (NASDAQ: RBCN) shares surged 66.1% to settle...
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension Nov 24, 2021 Benzinga Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces Receipt Of Patent Extension...
A Peek Into The Markets: US Stock Futures Down Following Friday's Rally Jul 26, 2021 Benzinga Pre-open movers U.S. stock futures traded lower in early pre-market trade after all three major indexes settled at record highs in the previous session. China...
5 Stocks To Watch For July 26, 2021 Jul 26, 2021 Benzinga Some of the stocks that may grab investor focus today are: Wall Street expects Lockheed Martin Corporation (NYSE: LMT) to report quarterly earnings at $6.53...
58 Biggest Movers From Yesterday Apr 27, 2021 Benzinga Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its...